Review Article

Role of Killer Immunoglobulin-Like Receptor and Ligand Matching in Donor Selection

Table 1

Characteristics of studies analyzing KIRs or KIR ligands.

Reference Stem cell sourceT-cell depletionDonor typeHLA matchDiagnose

Ruggeri et al. 2002 [3]92PBAllRelatedHaploidenticalVarious
Bishara et al. 2004 [6]62PBNot allRelatedHaploidenticalVarious
Symons et al. 2010 [7]86BMNoneRelatedHaploidenticalVarious
Weisdorf et al. 2012 [8]24PBAllRelatedHaploidenticalMyeloid
Cook et al. 2004 [9]220??RelatedHLA matchLymphoid, myeloid
Hsu et al. 2005 [10]178BMAllSiblingHLA matchVarious
Dalva et al. 2006 [11]84PB/BMNoneSiblingHLA matchVarious
McQueen et al. 2007 [5]202PB (89%)/BMNoneSiblingHLA matchVarious
Kim et al. 2007 [12]53BM/PBNoneSiblingHLA matchMyeloid
Giebel et al. 2009 [13]100PB/BMAllSibling/unrelatedHLA match (81%)Various
Stringaris et al. 2010 [14]246PB/BMAllSiblingHLA matchMyeloid
Davies et al. 2002 [15]175BM34%UnrelatedHLA mismatchVarious
Giebel et al. 2003 [16]130BM (96%)81%UnrelatedHLA match (47%)Various
Bornhäuser et al. 2004 [17]118BM/PBAllUnrelatedHLA match (46%)Myeloid
Schaffer et al. 2004 [18]190BM/PBAllUnrelatedHLA match (49%)Various
Beelen et al. 2005 [19]374BM/PBNoneUnrelated (60%)HLA match (63%)CML (63 %)
De Santis et al.
2005 [20]
104BM/PB14% (BM)UnrelatedHLA mismatchVarious
Kröger et al. 2005 [21]73PB (63%)/BMAllUnrelatedHLA match (86%)Myeloma
Farag et al. 2006 [22]1571BMNoneUnrelatedHLA match (64%)Various
Miller et al. 2007 [23]1770PB/BMNoneUnrelatedHLA matchVarious
Yabe et al. 2008 [24]1489BMAllUnrelatedHLA matchVarious
Cooley 2009 [25]448?NoneUnrelatedHLA match (47%)Myeloid
Cooley et al. 2010 [26]1086?NoneUnrelatedHLA match (50%)Myeloid, lymphoid
Gagne et al. 2009 [4]264BMNoneUnrelated
HLA match (62 %)Various
Venstrom et al. 2010 [27]1087BM (97%)19%UnrelatedHLA match (62%)Myeloid, lymphoid
Brunstein et al. 2009 [28]257CB32%UnrelatedHLA mismatch (92%)Various
Willemze et al. 2009 [29]218CB81%UnrelatedHLA mismatchVarious

BM: bone marrow, PB: peripheral blood, CB: cord blood, and CML: chronic myeloid leukemia.